Gadoversetamide is a gadolinium-based MRI contrast agent, particularly for imaging of the brain, spine and liver.[1][2] It is marketed under the trade name OptiMARK.
Clinical data | |
---|---|
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
License data |
|
Routes of administration | Intravenous |
ATC code |
|
Pharmacokinetic data | |
Protein binding | Nil |
Metabolism | Nil |
Elimination half-life | 80 to 120 minutes |
Excretion | Renal |
Identifiers | |
CAS Number |
|
PubChem CID |
|
DrugBank |
|
ChemSpider |
|
UNII |
|
KEGG |
|
ChEMBL |
|
CompTox Dashboard (EPA) |
|
Chemical and physical data | |
Formula | C20H34GdN5O10 |
Molar mass | 661.77 g·mol−1 |
3D model (JSmol) |
|
| |
| |
(what is this?) (verify) |